BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 5750213)

  • 1. [Studies on serum haptoglobin--on changes of serum haptoglobin levels in liver injury and effects of vitamins C and K1 upon serum haptoglobin levels].
    Morita M
    Sapporo Igaku Zasshi; 1968 Jun; 33(6):326-51. PubMed ID: 5750213
    [No Abstract]   [Full Text] [Related]  

  • 2. [Decrease of haptoglobin serum level in patients with chronic viral hepatitis C].
    Bacq Y; Schillio Y; Brechot JF; De Muret A; Dubois F; Metman EH
    Gastroenterol Clin Biol; 1993; 17(5):364-9. PubMed ID: 8349072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum haptoglobin levels in healthy and diseased individuals].
    Morita K; Mizuochi K; Sato S
    Nihon Hoigaku Zasshi; 1984 Apr; 38(2):177-82. PubMed ID: 6482071
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical significance of haptoglobin in chronic hepatitis and liver cirrhosis of viral etiology].
    Denisenko LN
    Ter Arkh; 1971 Oct; 43(10):38-41. PubMed ID: 5140948
    [No Abstract]   [Full Text] [Related]  

  • 5. Haptoglobin levels in liver cirrhosis.
    Baxi AJ; Ektare AM; Vora KK; Shah MJ; Mehta JM; Sheth UK
    Indian J Med Res; 1970 Oct; 58(10):1392-6. PubMed ID: 5501448
    [No Abstract]   [Full Text] [Related]  

  • 6. [Haptoglobin and hemopexin in the chronic hepatopathies].
    Pérez Blanco FJ; Rodríguez Cuartero A; Núñez Carril J; Mora Lara RJ
    Rev Esp Enferm Apar Dig; 1982 Jul; 62(1):20-4. PubMed ID: 7100594
    [No Abstract]   [Full Text] [Related]  

  • 7. [Determination of serum levels of haptoglobin during various liver diseases. Comparative evaluation with the determination of transaminases in the differential diagnosis of liver diseases].
    Piccinino F; Da Villa G; Giusti G
    Minerva Med; 1966 Dec; 57(101):4331-5. PubMed ID: 5958225
    [No Abstract]   [Full Text] [Related]  

  • 8. [Serum haptoglobin types in liver diseases].
    Marĕcek Z; Hoenigová J
    Experientia; 1970 Oct; 26(10):1096-7. PubMed ID: 5483756
    [No Abstract]   [Full Text] [Related]  

  • 9. Haptoglobin and caeruloplasmin in diseases of the liver and biliary tract.
    Prellwitz W; Hammar CH; Dudeck J
    Ger Med Mon; 1969 Jan; 14(1):23-7. PubMed ID: 5352740
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of clinical factors on the haemolysis marker haptoglobin.
    Körmöczi GF; Säemann MD; Buchta C; Peck-Radosavljevic M; Mayr WR; Schwartz DW; Dunkler D; Spitzauer S; Panzer S
    Eur J Clin Invest; 2006 Mar; 36(3):202-9. PubMed ID: 16506966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum haptoglobin type and liver cirrhosis.
    Hirayama C; Nakamura M; Koga S
    Humangenetik; 1975 Jun; 28(2):139-46. PubMed ID: 1150267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of serum hepatocyte growth factor levels in liver diseases.
    Hioki O; Watanabe A; Minemura M; Tsuchida T
    J Med; 1993; 24(1):35-46. PubMed ID: 7684768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocyte growth factor and acute phase proteins in patients with chronic liver diseases.
    Shiota G; Umeki K; Okano J; Kawasaki H
    J Med; 1995; 26(5-6):295-308. PubMed ID: 8721905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical value of the determination of fasting glycocholic acid serum levels in patients with liver diseases. A comparison with standard liver tests.
    Collazos J; Mendarte U; De Miguel J
    Gastroenterol Clin Biol; 1993; 17(2):79-82. PubMed ID: 8500713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on the action of C-reactive proteins in relation to current liver tests].
    Renger F; Kanehl R; Kanehl E
    Acta Hepatosplenol; 1965; 12(6):337-51. PubMed ID: 5868476
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts.
    Koruk M; Onuk MD; Akçay F; Savas MC
    Hepatogastroenterology; 2002; 49(48):1645-8. PubMed ID: 12397754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of diseases of the liver on serum 25-hydroxyvitamin D and on the serum binding protein for vitamin D and its metabolites.
    Imawari M; Akanuma Y; Itakura H; Muto Y; Kosaka K; Goodman DS
    J Lab Clin Med; 1979 Jan; 93(1):171-80. PubMed ID: 569678
    [No Abstract]   [Full Text] [Related]  

  • 18. Relationship between thrombopoietin serum levels and liver function in patients with chronic liver disease related to hepatitis C virus infection.
    Giannini E; Botta F; Borro P; Malfatti F; Fumagalli A; Testa E; Podestà E; Chiarbonello B; Polegato S; Mamone M; Testa R
    Am J Gastroenterol; 2003 Nov; 98(11):2516-20. PubMed ID: 14638357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes of some vitamin levels in plasma in patients with chronic liver diseases].
    Dítĕ P; Nerad V; Fendrichová M; Skaunic V; Groh J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1975; 18(3):541-6. PubMed ID: 1071831
    [No Abstract]   [Full Text] [Related]  

  • 20. [Quantitative behavior of haptoglobins (Hp) in the course of some parenchymal diseases of the liver].
    Bogdal J
    Folia Med Cracov; 1971; 13(3):353-74. PubMed ID: 5139801
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.